Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Champions Oncology (CSBR) Receivables - Other (2017 - 2026)

Champions Oncology has reported Receivables - Other over the past 16 years, most recently at $6.2 million for Q1 2026.

  • For Q1 2026, Receivables - Other rose 6.36% year-over-year to $6.2 million; the TTM value through Jan 2026 reached $6.2 million, up 6.36%, while the annual FY2025 figure was $5.4 million, 9.14% down from the prior year.
  • Receivables - Other for Q1 2026 was $6.2 million at Champions Oncology, down from $7.2 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $7.2 million in Q4 2025 and troughed at $3.7 million in Q1 2023.
  • A 5-year average of $5.1 million and a median of $5.0 million in 2023 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: fell 10.7% in 2023 and later skyrocketed 65.77% in 2024.
  • Year by year, Receivables - Other stood at $4.3 million in 2022, then decreased by 7.28% to $4.0 million in 2023, then skyrocketed by 65.77% to $6.6 million in 2024, then rose by 8.09% to $7.2 million in 2025, then decreased by 14.17% to $6.2 million in 2026.
  • Business Quant data shows Receivables - Other for CSBR at $6.2 million in Q1 2026, $7.2 million in Q4 2025, and $5.3 million in Q3 2025.